{"id":"https://openalex.org/W4244987958","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct141","title":"Abstract CT141: Genetic landscape of premenopausal HR+/HER2- advanced breast cancer (ABC) based on comprehensive circulating tumor DNA analysis and association with clinical outcomes in the Phase III MONALEESA-7 trial","display_name":"Abstract CT141: Genetic landscape of premenopausal HR+/HER2- advanced breast cancer (ABC) based on comprehensive circulating tumor DNA analysis and association with clinical outcomes in the Phase III MONALEESA-7 trial","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4244987958","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct141"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-ct141","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct141","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct141","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005415248","display_name":"Faye Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Faye Su","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041227452","display_name":"Nadia Solovieff","orcid":"https://orcid.org/0000-0001-6140-7304","observed_orcids":["https://orcid.org/0000-0001-6140-7304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadia Solovieff","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Inc, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Inc, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069050806","display_name":"Seock\u2010Ah Im","orcid":"https://orcid.org/0000-0002-5396-6533","observed_orcids":["https://orcid.org/0000-0002-5396-6533"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seock-Ah Im","raw_affiliation_strings":["Seoul National University Hospital Cancer Research Institute, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Hospital Cancer Research Institute, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030577122","display_name":"Joohyuk Sohn","orcid":"https://orcid.org/0000-0002-2303-2764","observed_orcids":["https://orcid.org/0000-0002-2303-2764"]},"institutions":[{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Joohyuk Sohn","raw_affiliation_strings":["Yonsei University Health System, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yonsei University Health System, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4210160791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038366277","display_name":"Keun Seok Lee","orcid":"https://orcid.org/0000-0001-5575-836X","observed_orcids":["https://orcid.org/0000-0001-5575-836X"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Keun Seok Lee","raw_affiliation_strings":["Seoul National University Hospital, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047747904","display_name":"Sa\u00fal Campos-G\u00f3mez","orcid":"https://orcid.org/0000-0002-1804-2589","observed_orcids":["https://orcid.org/0000-0002-1804-2589"]},"institutions":[{"id":"https://openalex.org/I4405261060","display_name":"Instituto de Seguridad Social del Estado de M\u00e9xico y Municipios","ror":"https://ror.org/04pvd4f07","country_code":"MX","type":"government","lineage":["https://openalex.org/I4405261060"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Saul Campos-Gomez","raw_affiliation_strings":["Instituto de Seguridad Social del Estado de M\u00e9xico y Municipios, Toluca, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Seguridad Social del Estado de M\u00e9xico y Municipios, Toluca, Mexico","institution_ids":["https://openalex.org/I4405261060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049348377","display_name":"Kyung Hae Jung","orcid":"https://orcid.org/0000-0002-1580-7224","observed_orcids":["https://orcid.org/0000-0002-1580-7224"]},"institutions":[{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Kyung Hae Jung","raw_affiliation_strings":["University of Ulsan College of Medicine, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Ulsan College of Medicine, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081825777","display_name":"Rafael Villanueva-V\u00e1zquez","orcid":"https://orcid.org/0000-0003-4730-6886","observed_orcids":["https://orcid.org/0000-0003-4730-6886"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Villanueva Vazquez","raw_affiliation_strings":["Institut Catal\u00e0 d'Oncologia, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Catal\u00e0 d'Oncologia, Barcelona, Spain","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009846821","display_name":"Yen\u2010Shen Lu","orcid":"https://orcid.org/0000-0001-7461-1291","observed_orcids":["https://orcid.org/0000-0001-7461-1291"]},"institutions":[{"id":"https://openalex.org/I4210131804","display_name":"National Taiwan University Hospital","ror":"https://ror.org/03nteze27","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210131804"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"Yen-Shen Lu","raw_affiliation_strings":["National Taiwan University Hospital, Taipei City, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Taiwan University Hospital, Taipei City, Taiwan","institution_ids":["https://openalex.org/I4210131804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072563857","display_name":"Fabio Andre Franke","orcid":"https://orcid.org/0000-0002-9417-2123","observed_orcids":["https://orcid.org/0000-0002-9417-2123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabio Franke","raw_affiliation_strings":["M\u00e9dico Oncologista Cl\u00ednico Coordenador do Cacon, Iju\u00ed, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M\u00e9dico Oncologista Cl\u00ednico Coordenador do Cacon, Iju\u00ed, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Hurvitz","raw_affiliation_strings":["The University of California, Los Angeles (UCLA), Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of California, Los Angeles (UCLA), Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027231412","display_name":"Nadia Harbeck","orcid":"https://orcid.org/0000-0002-9744-7372","observed_orcids":["https://orcid.org/0000-0002-9744-7372"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nadia Harbeck","raw_affiliation_strings":["Ludwig-Maximilians-Universitat Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig-Maximilians-Universitat Munich, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Louis Chow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louis Chow","raw_affiliation_strings":["Organisation for Oncology and Translational Research, Hong Kong, Hong Kong"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organisation for Oncology and Translational Research, Hong Kong, Hong Kong","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006919907","display_name":"Karen Rodriguez Lorenc","orcid":"https://orcid.org/0009-0007-1286-7778","observed_orcids":["https://orcid.org/0009-0007-1286-7778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Rodriguez Lorenc","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113735301","display_name":"Tetiana Taran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetiana Taran","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110623859","display_name":"Naveen Babbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Babbar","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, Cambridge, MA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"CT141","last_page":"CT141"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/premenopausal-breast-cancer","display_name":"premenopausal breast cancer","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-4-6-inhibitors","display_name":"cyclin-dependent kinase 4/6 inhibitors","score":0.890999972820282},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.718999981880188},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.7039999961853027},{"id":"https://openalex.org/keywords/goserelin","display_name":"goserelin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9129999876022339},{"id":"https://openalex.org/keywords/anastrozole","display_name":"anastrozole","score":0.9869999885559082},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.996999979019165},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9259999990463257},{"id":"https://openalex.org/keywords/ccnd1","display_name":"CCND1","score":0.9210000038146973},{"id":"https://openalex.org/keywords/gata3","display_name":"GATA3","score":0.9900000095367432},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.8579999804496765},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.7385901212692261},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.728365421295166},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7014373540878296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6783007383346558},{"id":"https://openalex.org/C2776215463","wikidata":"https://www.wikidata.org/wiki/Q419143","display_name":"Anastrozole","level":5,"score":0.588575541973114},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5629488229751587},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5572044253349304},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.45247119665145874},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.44488459825515747},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4366440773010254},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.4313584566116333},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.40602660179138184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12296342849731445},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11741924285888672},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-ct141","doi":"https://doi.org/10.1158/1538-7445.sabcs18-ct141","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-ct141","pdf_url":null,"source":{"id":"https://openalex.org/S59378366","display_name":"Clinical Trials","issn_l":"1740-7745","issn":["1740-7745","1740-7753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Trials","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3197298803","https://openalex.org/W2947234394","https://openalex.org/W2953995390","https://openalex.org/W3203029164","https://openalex.org/W2943879513","https://openalex.org/W2939542194","https://openalex.org/W2898479222","https://openalex.org/W2898186613","https://openalex.org/W2789830499","https://openalex.org/W2901832580"],"abstract_inverted_index":{"Background:":[0],"The":[1,14,249],"genetic":[2,250],"landscape":[3,251,421],"of":[4,23,49,119,129,180,188,233,252,259,350,422,450],"premenopausal":[5,33,246,253,423],"hormone":[6],"receptor-positive":[7],"(HR+)":[8],"ABC":[9,89,254],"is":[10],"not":[11,312],"well":[12],"understood.":[13],"Phase":[15,443],"III":[16,444],"MONALEESA-7":[17,445],"study":[18],"(NCT02278120),":[19],"the":[20,47,133,141,257,442,451],"first":[21],"trial":[22,446],"endocrine":[24],"therapy":[25,242],"\u00b1":[26],"a":[27,53,78,196],"cyclin-dependent":[28],"kinase":[29,222,357],"4/6":[30],"inhibitor":[31,56],"for":[32,110,198,243,348,454],"patients":[34,168],"(pts)":[35],"with":[36,87,136,169,202,212,245,438],"HR+/human":[37],"epidermal":[38],"growth":[39],"factor":[40],"receptor":[41,220],"2-negative":[42],"(HER2-)":[43],"ABC,":[44],"demonstrated":[45],"that":[46],"addition":[48],"ribociclib":[50],"(RIB)":[51],"to":[52,93],"nonsteroidal":[54,315],"aromatase":[55,316],"(NSAI)":[57],"or":[58,95,102,104],"tamoxifen":[59],"(TAM)":[60],"+":[61,98,106,204,206,225,227,271,273,275,277],"goserelin":[62],"(GOS)":[63],"significantly":[64],"extended":[65],"progression-free":[66,327],"survival":[67],"(PFS;":[68],"Tripathy":[69],"D,":[70],"et":[71],"al.":[72],"Lancet":[73],"Oncol.":[74],"2018).":[75],"We":[76],"conducted":[77],"comprehensive":[79,431],"ctDNA":[80,111,121,137],"genomic":[81],"analysis":[82,112,435],"from":[83],"MONALEESA-7.Methods:":[84],"Premenopausal":[85],"pts":[86,135,211,244],"HR+/HER2-":[88,247,424],"were":[90,113,145],"randomized":[91],"1:1":[92],"RIB":[94,181,203,224,351],"placebo":[96],"(PBO)":[97],"NSAI":[99],"(letrozole":[100],"[LET]":[101],"anastrozole)":[103],"TAM":[105],"GOS.":[107],"Plasma":[108],"samples":[109],"collected":[114],"at":[115,139],"baseline":[116,234],"and":[117,155,171,216,238,371,377,436],"end":[118],"treatment.":[120],"was":[122,164,182,208],"analyzed":[123,138],"using":[124],"next-generation":[125],"sequencing":[126],"(targeted":[127],"panel":[128],"550":[130],"genes).Results:":[131],"Among":[132],"489":[134],"baseline,":[140],"most":[142,165],"common":[143],"alterations":[144],"in":[146,160,167,178,184,210,219,267,441],"PIK3CA":[147],"(28%),":[148],"TP53":[149,170],"(19%),":[150],"CCND1":[151],"(11%),":[152],"MYC":[153,172,319],"(8%),":[154],"GATA3":[156],"(8%).":[157],"Poorer":[158],"prognosis":[159],"both":[161],"treatment":[162,176],"groups":[163],"evident":[166],"alterations.":[173],"A":[174],"PFS":[175,230,349],"effect":[177],"favor":[179],"noted":[183],"all":[185],"subsets,":[186],"independent":[187],"biomarker":[189,235,269],"status":[190,237],"(Table).":[191],"However,":[192],"based":[193,429],"on":[194,430],"HR,":[195],"trend":[197],"more":[199],"pronounced":[200],"benefit":[201,231],"NSAI/TAM":[205,226,272,276],"GOS":[207,228],"observed":[209],"altered":[213],"CCND1,":[214,298],"GATA3,":[215,304],"genes":[217,358],"involved":[218],"tyrosine":[221,288,356],"signaling.Conclusions:":[223],"provided":[229],"irrespective":[232],"alteration":[236],"represents":[239],"recommended":[240],"first-line":[241],"ABC.":[248],"might":[255],"modulate":[256],"magnitude":[258],"therapeutic":[260],"benefit;":[261],"these":[262],"novel":[263],"findings":[264],"require":[265],"confirmation":[266],"additional":[268],"studies.RIB":[270],"GOSPBO":[274],"GOSEvents,":[278],"n/NPFS,":[279,282],"median":[280],"monthsEvents,":[281],"median,":[283],"monthsHRa":[284],"(95%":[285],"CI)PIK3CAWT68/18024.6798/17012.190.45":[286],"(0.33-0.62)Alt38/6914.7546/7012.850.57(0.36-0.9)TP53WT78/20324.67109/19412.980.48(0.36-0.65)Alt28/469.2335/467.160.47(0.27-0.82)CCND1WT91/22122.11126/21712.880.52(0.39-0.68)Alt15/2811.2718/235.520.21(0.08-0.54)MYCWT90/22924.67125/22112.880.49(0.37-0.65)Alt16/207.3419/197.160.57(0.25-1.31)GATA3WT96/22622.11131/22212.850.52(0.39-0.68)Alt10/23NA13/185.520.18(0.05-0.62)Receptor":[287],"kinasesbWT76/19827.53114/20614.520.5(0.37-0.67)Alt30/5114.5530/345.650.26(0.14-0.47)8p11.23cWT84/21523.03124/21412.780.47(0.36-0.63)Alt22/3412.5220/269.130.51(0.26-1)8p11.23,":[289],"chromosome":[290],"8,":[291],"short":[292],"arm,":[293],"region":[294],"11.23;":[295],"alt,":[296],"alteration;":[297],"cyclin":[299],"D1;":[300],"CI,":[301],"confidence":[302],"interval;":[303],"GATA":[305],"binding":[306],"protein":[307,342],"3;":[308,463],"GOS,":[309],"goserelin;":[310],"NA,":[311],"applicable;":[313],"NSAI,":[314],"inhibitor;":[317],"MYC,":[318],"proto-oncogene,":[320],"bHLH":[321],"transcription":[322],"factor;":[323],"PBO,":[324],"placebo;":[325],"PFS,":[326],"survival;":[328],"PIK3CA,":[329],"phosphatidylinositol":[330],"4,5-bisphosphate":[331],"3-kinase":[332],"catalytic":[333],"subunit":[334],"\u03b1;":[335],"RIB,":[336],"ribociclib;":[337],"TAM,":[338],"tamoxifen;":[339],"TP53,":[340],"tumor":[341,433],"p53;":[343],"WT,":[344],"wild":[345],"type.a":[346],"HR":[347],"vs":[352],"PBO.":[353],"b":[354],"Receptor":[355],"include":[359],"EGFR,":[360],"ERBB2,":[361],"ERBB3,":[362],"ERBB4,":[363],"FGFR1,":[364,375],"IGF1,":[365],"IGF1R,":[366],"KDR,":[367],"KIT,":[368],"PDGFRA,":[369],"PDGFRB,":[370],"VEGFA.":[372],"c":[373],"Includes":[374],"WHSC1L1,":[376],"ZNF703.Citation":[378],"Format:":[379],"Aditya":[380],"Bardia,":[381],"Faye":[382],"Su,":[383],"Nadia":[384,407],"Solovieff,":[385],"Seock-Ah":[386],"Im,":[387],"Joohyuk":[388],"Sohn,":[389],"Keun":[390],"Seok":[391],"Lee,":[392],"Saul":[393],"Campos-Gomez,":[394],"Kyung":[395],"Hae":[396],"Jung,":[397],"Rafael":[398],"Villanueva":[399],"Vazquez,":[400],"Yen-Shen":[401],"Lu,":[402],"Fabio":[403],"Franke,":[404],"Sara":[405],"Hurvitz,":[406],"Harbeck,":[408],"Louis":[409],"Chow,":[410],"Karen":[411],"Rodriguez":[412],"Lorenc,":[413],"Tetiana":[414],"Taran,":[415],"Naveen":[416],"Babbar,":[417],"Debu":[418],"Tripathy.":[419],"Genetic":[420],"advanced":[425],"breast":[426],"cancer":[427],"(ABC)":[428],"circulating":[432],"DNA":[434],"association":[437],"clinical":[439],"outcomes":[440],"[abstract].":[447],"In:":[448],"Proceedings":[449],"American":[452],"Association":[453],"Cancer":[455,469],"Research":[456],"Annual":[457],"Meeting":[458],"2019;":[459],"2019":[460],"Mar":[461],"29-Apr":[462],"Atlanta,":[464],"GA.":[465],"Philadelphia":[466],"(PA):":[467],"AACR;":[468],"Res":[470],"2019;79(13":[471],"Suppl):Abstract":[472],"nr":[473],"CT141.":[474]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-05-12T00:00:00"}